This article is more than 5 years old. Information may no longer be current.

Alcon reports single-digit growth in second quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Alcon reported $2.6 billion in net sales and an underlying growth of 2% in the second quarter of 2015, according to a Novartis press release.

“This was driven by lower sales in the U.S. and Asia, which resulted from a slowdown in our surgical equipment sales as well as softer IOL sales due to mix and pricing challenges despite strong continued unit growth, and an accelerated decline in our contact lens care solutions business,” Jeff George, Global Head of Alcon, said in a video presentation.

Core operating income declined 10% from the second quarter of the previous year to $796 million in the second quarter of 2015.

In the first half of 2015, surgical sales increased 2%, ophthalmic pharmaceuticals grew 3% and vision care increased 1%.

The company hopes to increase growth after the recent European CE mark approvals of the AcrySof IQ PanOptix trifocal IOL and the UltraSert preloaded IOL delivery system, George said.